-
Metronidazole: The OAT3–Microbiome Bridge
2026-09-12
Metronidazole is more than a familiar nitroimidazole antibiotic: its reported OAT3 inhibition creates a valuable platform for connecting anaerobic-bacteria targeting, transporter biology, and drug–drug interaction research. This thought-leadership perspective outlines how translational teams can validate that dual role while avoiding overinterpretation.
-
nPEC for Dual-Loaded Liposome Encapsulation
2026-09-11
The reference study systematically compares separation workflows for measuring the encapsulation efficiency of liposomes carrying hydrophilic and lipophilic drugs together. Its main contribution is a validated nanoparticle exclusion chromatography method that enables simultaneous, online quantification of free and encapsulated drug without pretreatment, offering a practical alternative to more formulation-dependent assays.
-
Exo1 Workflows for Membrane Trafficking Studies
2026-09-11
Exo1 enables acute, mechanistically distinctive membrane trafficking inhibition for Golgi–ER transport studies and exocytosis assays. This guide translates its ARF1-linked phenotype into practical workflows for secretion, extracellular-vesicle, and tumor communication research while separating established evidence from experimental extensions.
-
EdU Flow Cytometry Assay Kits: Practical Guide
2026-09-10
EdU Flow Cytometry Assay Kits (Cy3) provide a denaturation-free way to connect DNA synthesis with cell identity, cell-cycle position, and treatment response. This practical guide explains workflow design, multiplexing, UCEC-focused applications, and troubleshooting for reproducible proliferation measurements.
-
Cyanidin Chloride: A Redox Assay Decision Guide
2026-09-10
Cyanidin Chloride supports a disciplined progression from chemical radical-scavenging assays to cellular oxidative stress research. This guide clarifies its identity, separates aglycone evidence from glycoside findings, and translates the 2024 keratinocyte study into practical assay decisions.
-
PZP Links Intermittent Fasting to Brown-Fat Thermogenesis
2026-09-09
The reference study identifies pregnancy zone protein (PZP) as a liver-derived signal that rises during refeeding and promotes diet-induced thermogenesis in brown adipose tissue. Its proposed PZP–GRP78–p38 MAPK–ATF2–UCP1 axis provides a mechanistic explanation for endocrine communication between the liver and brown fat during intermittent fasting.
-
Proteoform-Specific Drug Targeting in Native Membranes
2026-09-09
Lutomski et al. developed a native top-down mass spectrometry workflow that releases membrane proteins and signaling complexes directly from retinal disc membranes while preserving proteoform-dependent interactions. The study reveals how lipid modifications shape rhodopsin and G-protein behavior and shows that sildenafil and vardenafil display differential off-target reactivity with retinal PDE6.
-
PPM-18 for iNOS and NF-κB Research
2026-09-08
PPM-18 provides a practical way to separate NF-κB-driven iNOS expression from direct nitric oxide synthase catalysis in inflammation and sepsis research. This workflow-focused guide covers DMSO handling, LPS challenge design, orthogonal readouts, and assay troubleshooting while translating insights from a bone-remodeling study into defensible experimental choices.
-
Neurotensin for GPCR Trafficking Studies
2026-09-07
Build a controlled Neurotensin workflow for NTR1 signaling, receptor recycling, and miR-133α measurements in gastrointestinal cell models. This guide combines practical peptide handling with an evidence-aware strategy for managing analytical interference and improving assay reproducibility.
-
BFH772 (VEGFR2 inhibitor): Practical Lab Guide
2026-09-07
BFH772 is a selective VEGFR2 inhibitor for studies that require controlled perturbation of VEGFR2-dependent signaling and angiogenesis rather than broad kinase inhibition. Its water insolubility and dependence on organic solvents make it unsuitable for workflows requiring direct aqueous formulation, while its reported 3 nM VEGFR2 kinase IC50 supports use as a reference compound in biochemical and cellular assay development.
-
3X (DYKDDDDK) Peptide in Cell Assays
2026-09-05
Learn how 3X (DYKDDDDK) Peptide, SKU A6001, supports identity, recovery, and exposure controls in recombinant-protein workflows connected to cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers compatibility, storage, metal-sensitive detection, interpretation, and practical vendor selection.
-
Resiniferatoxin: TRPV1 Precision Beyond Analgesia
2026-09-05
Resiniferatoxin is more than an ultra-potent TRPV1 agonist: it is a context-sensitive tool for separating calcium signaling, sensory-neuron desensitization, and durable functional silencing. This thought-leadership perspective connects RTX assay design with translational pain research while examining an important immune-oncology caveat from metastatic breast cancer models.
-
Microlipophagy and Radioresistance in SCLC
2026-09-04
A 2026 study identifies microlipophagy-driven lipid droplet remodeling as a metabolic adaptation associated with radioresistant small-cell lung cancer. By combining imaging, lipid measurements, pharmacological autophagy inhibition, and transcriptomics, the authors show that disrupting this pathway can restore radiation sensitivity in resistant cells.
-
Dehydroabietic acid: Design Better PPAR Assays
2026-09-04
Dehydroabietic acid can help researchers separate receptor-driven transcription from substrate-driven metabolic effects. This article presents a time-resolved assay framework for studying dual PPAR-α/γ agonism, lipid metabolism regulation, and metabolic disorder research.
-
Firefly Luciferase mRNA: Reliable Assay Workflows
2026-09-03
Learn how EZ Cap™ Firefly Luciferase mRNA (5-moUTP), SKU R1013, can address inconsistent reporter expression, delivery variability, and interpretation challenges in cell viability and cytotoxicity workflows. This scenario-based guide connects product specifications with practical controls and recent evidence on small-scale mRNA delivery systems.